Alban Arrault
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alban Arrault has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Philippe Vayer
Technologie Servier
2 shared publications - Bernard Walther
Pharmacokinetic and Metabolism Centre, Technologie Servier, 27 rue E. Vignat, 45000 Orleans, France
1 shared publication Brigitte Lesur
1 shared publication- Lionel Colliandre
Institut de Chimie Organique et Analytique (ICOA), Université d’Orléans, UMR CNRS 7311 B.P. 6759, rue de Chartres, 45067 Orléans Cedex 2, France
1 shared publication - Luc Morin-Allory
Institut de Chimie Organique et Analytique (ICOA), Université d’Orléans, UMR CNRS 7311 B.P. 6759, rue de Chartres, 45067 Orléans Cedex 2, France
1 shared publication Marc Bertrand
1 shared publication
Latest Publications
- Open Access
- 31 August 2012
- Published by Springer Nature in Journal of Cheminformatics
- Vol. 4 (1) , 20
Mining collections of compounds with Screening Assistant 2
High-throughput screening assays have become the starting point of many drug discovery programs for large pharmaceutical companies as well as academic organisations. Despite the increasing throughput of screening technologies, the almost infinite chemical space remains out of reach, calling for tools dedicated to the analysis and selection of the compound collections intended to be screened.
- 31 August 2012
- Published by Springer Nature in Journal of Cheminformatics
- Vol. 4 (1) , 20
Open AccessMining collections of compounds with Screening Assistant 2
High-throughput screening assays have become the starting point of many drug discovery programs for large pharmaceutical companies as well as academic organisations. Despite the increasing throughput of screening technologies, the almost infinite chemical space remains out of reach, calling for tools dedicated to the analysis and selection of the compound collections intended to be screened.
- 15 October 2009
- Published by EDP Sciences in médecine/sciences
- Vol. 25 (10)
Apports de la chémo-informatique dans la recherche et l’optimisation des molécules d’intérêt thérapeutique
Successful identification of new chemical entities with drug-like properties in pharmaceutical and academic research groups involves an early screen and the use of a large number of public and proprietary chemical libraries. Before applying high-throughput experimental screening approaches, virtual screening strategies have been put in place in order to sort and filter this massive amount of compounds and data available at these very early stages. Chemoinformatic tools have a crucial role in this selection process and enable therapeutic chemists to focus very early on promising candidates. Virtual screening has conventionally been based either on models of the target or the ligand (molecule), but today these models include biopharmaceutical filters addressing right from the start of the project the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of the molecules. Above all, chemoinformatic tools help chemists understand better the chemical diversity they can work with, especially when comparing chemical libraries. This paper will focus on exemples of the day-to-day use of chemoinformatics in screening programs. A large part will be dedicated to new tools (chemographic and pharmacographic approaches) being developed for the representation and analysis of chemical diversity, but also for combining chemical and biological information to expedite research programs.
- 15 October 2009
- Published by EDP Sciences in médecine/sciences
- Vol. 25 (10)
Apports de la chémo-informatique dans la recherche et l’optimisation des molécules d’intérêt thérapeutique
Successful identification of new chemical entities with drug-like properties in pharmaceutical and academic research groups involves an early screen and the use of a large number of public and proprietary chemical libraries. Before applying high-throughput experimental screening approaches, virtual screening strategies have been put in place in order to sort and filter this massive amount of compounds and data available at these very early stages. Chemoinformatic tools have a crucial role in this selection process and enable therapeutic chemists to focus very early on promising candidates. Virtual screening has conventionally been based either on models of the target or the ligand (molecule), but today these models include biopharmaceutical filters addressing right from the start of the project the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of the molecules. Above all, chemoinformatic tools help chemists understand better the chemical diversity they can work with, especially when comparing chemical libraries. This paper will focus on exemples of the day-to-day use of chemoinformatics in screening programs. A large part will be dedicated to new tools (chemographic and pharmacographic approaches) being developed for the representation and analysis of chemical diversity, but also for combining chemical and biological information to expedite research programs.